Alfa Chemistry, a long-term partner for many pharmaceutical companies, universities, and research institutions, recently announced to offer donepezil, a synthetic active pharmaceutical ingredient (API) that can be used in pharmaceutical preparation for the treatment of Alzheimer's disease. API refers to the biologically active component of a drug product. In recent decades, the great importance...

The Alzheimer’s Disease Treatment Market sector is undergoing rapid transformation, with significant growth and innovations expected by 2029. In-depth market research offers a thorough analysis of market size, share, and emerging trends, providing essential insights into its expansion potential. The report explores market segmentation and definitions, emphasizing key components...

The Limitations of Traditional Models For decades, two-dimensional (2D) cell cultures and animal models have been the cornerstone of biomedical research and drug development. While these methods have yielded important insights, they often fall short in replicating the complex biological environment of the human body. Cells grown in a flat monolayer do not accurately mimic in vivo...

  Modern medicine stands at the threshold of a computational renaissance, where biological complexity meets algorithmic sophistication to unlock unprecedented therapeutic possibilities. As healthcare systems confront rising costs and limited treatment options for complex diseases, generative AI in pharma emerges as the cornerstone of a new therapeutic paradigm, fundamentally altering our...

Protheragen, a reputable research service provider in the life science industry, proudly introduces its comprehensive therapeutic development solutions covering a full spectrum of ophthalmic drug preclinical R&D services tailored specifically for ophthalmic research. These innovative initiatives help researchers streamline the complex process of developing effective therapies for eye...

Rare diseases affect millions of individuals worldwide, yet the complexity of researching these conditions makes global trials both essential and ethically challenging. With small, dispersed patient populations, high stakes for treatment, and diverse regulatory environments, rare disease trials require ethical rigor at every stage. Upholding integrity and fairness is not...